Authors:
Modugno, F
Weissfeld, JL
Trump, DL
Zmuda, JM
Shea, P
Cauley, JA
Ferrell, RE
Citation: F. Modugno et al., Allelic variants of aromatase and the androgen and estrogen receptors: Toward a multigenic model of prostate cancer risk, CLIN CANC R, 7(10), 2001, pp. 3092-3096
Authors:
Fitzpatrick, AL
Daling, JR
Furberg, CD
Kronmal, RA
Weissfeld, JL
Citation: Al. Fitzpatrick et al., Hypertension, heart rate, use of antihypertensives, and incident prostate cancer, ANN EPIDEMI, 11(8), 2001, pp. 534-542
Authors:
Subar, AF
Ziegler, RG
Thompson, FE
Johnson, CC
Weissfeld, JL
Reding, D
Kavounis, KH
Hayes, RB
Citation: Af. Subar et al., Is shorter always better? Relative importance of questionnaire length and cognitive ease on response rates and data quality for two dietary questionnaires, AM J EPIDEM, 153(4), 2001, pp. 404-409
Authors:
Prorok, PC
Andriole, GL
Bresalier, RS
Buys, SS
Chia, D
Crawford, ED
Fogel, R
Gelmann, EP
Gilbert, F
Hasson, MA
Hayes, RB
Johnson, CC
Mandel, JS
Oberman, A
O'Brien, B
Oken, MM
Rafla, S
Reding, D
Rutt, W
Weissfeld, JL
Yokochi, L
Gohagan, JK
Citation: Pc. Prorok et al., Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, CONTR CL TR, 21(6), 2000, pp. 273S-309S
Authors:
Hayes, RB
Reding, D
Kopp, W
Subar, AF
Bhat, N
Rothman, N
Caporaso, N
Ziegler, RG
Johnson, CC
Weissfeld, JL
Hoover, RN
Hartge, P
Palace, C
Gohagan, JK
Citation: Rb. Hayes et al., Etiologic and early marker studies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, CONTR CL TR, 21(6), 2000, pp. 349S-355S
Citation: Jl. Weissfeld et al., Quality control of cancer screening examination procedures in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, CONTR CL TR, 21(6), 2000, pp. 390S-399S
Citation: Ab. Miller et al., Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, CONTR CL TR, 21(6), 2000, pp. 400S-406S
Citation: F. Modugno et al., Reproducibility in the assessment of postmenopausal ovaries with transvaginal ultrasound, GYNECOL ONC, 77(2), 2000, pp. 289-292
Authors:
Alexander, FE
Andriole, GL
Aus, G
Auvinen, A
Beensterboer, P
Blijenberg, BG
Bonardi, R
Buys, S
Candas, B
Ciatto, S
Crawford, ED
Demers, R
de Koning, HJ
Denis, L
Dijk, MA
Figueiredo, F
Gellman, EP
Gohagan, J
Hakama, M
Hugosson, J
Kirkels, WI
Kranse, R
van der Kwast, TH
Lilja, H
Maattanen, L
Mandel, J
Miller, AB
Monteiro, H
Nelen, V
Oberman, A
Paez, A
Prorok, PC
Reding, D
Rietbergen, JWBW
Rose, DB
Sanchez, AB
Schroder, FH
da Silva, EC
Simpson, N
Smith, PH
Stadaert, B
Stenman, UH
Teppo, L
Turkes, A
Weissfeld, JL
Yokochi, L
Citation: Fe. Alexander et al., Rationale for randomised trials of prostate cancer screening, EUR J CANC, 35(2), 1999, pp. 262-271